BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37968706)

  • 21. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma.
    Sun S; Ning X; Liu J; Liu L; Chen Y; Han S; Zhang Y; Liang J; Wu K; Fan D
    Biochem Biophys Res Commun; 2007 May; 356(4):864-71. PubMed ID: 17400182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells.
    Feng S; Zhou Q; Yang B; Li Q; Liu A; Zhao Y; Qiu C; Ge J; Zhai H
    PLoS One; 2018; 13(3):e0192208. PubMed ID: 29534068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey.
    Zhai H; Shi Y; Jin H; Li Y; Lu Y; Chen X; Wang J; Ding L; Wang X; Fan D
    J Histochem Cytochem; 2008 Aug; 56(8):765-72. PubMed ID: 18443365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis.
    Ning X; Sun S; Zhang K; Liang J; Chuai Y; Li Y; Wang X
    PLoS One; 2012; 7(1):e30185. PubMed ID: 22295074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CacyBP/SIP protein reduces p53 stability by enhancing Mdm2 activity in p53 mutant glioma cells.
    Qian F; Tang T; Wang S; Wang B; Wang L; Shi H
    Neoplasma; 2021 Jan; 68(1):119-125. PubMed ID: 32880469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
    Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
    Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
    Xu G; Feng D; Yao Y; Li P; Sun H; Yang H; Li C; Jiang R; Sun B; Chen Y
    Oncogene; 2020 Feb; 39(7):1429-1444. PubMed ID: 31659256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer.
    Ning X; Sun S; Hong L; Liang J; Liu L; Han S; Liu Z; Shi Y; Li Y; Gong W; Zhang S; Chen Y; Guo X; Cheng Y; Wu K; Fan D
    Mol Cancer Res; 2007 Dec; 5(12):1254-62. PubMed ID: 18171983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
    Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
    Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.
    Wan JL; Wang B; Wu ML; Li J; Gong RM; Song LN; Zhang HS; Zhu GQ; Chen SP; Cai JL; Xing XX; Wang YD; Yang Y; Cai CZ; Huang R; Liu H; Dai Z
    Cancer Lett; 2022 Aug; 541():215750. PubMed ID: 35609735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP.
    Chu Z; Wang C; Tang Q; Shi X; Gao X; Ma J; Lu K; Han Q; Jia Y; Wang X; Adam FEA; Liu H; Xiao S; Wang X; Yang Z
    Front Cell Infect Microbiol; 2018; 8():304. PubMed ID: 30234028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension.
    Zhou J; Li F; Yang Y
    Respir Res; 2022 Aug; 23(1):223. PubMed ID: 36042446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CacyBP/SIP protein is important for the proliferation of human glioma cells.
    Shi H; Gao Y; Tang Y; Wu Y; Gong H; Du J; Zheng B; Hu J; Shi Q; Yu R
    IUBMB Life; 2014 Apr; 66(4):286-91. PubMed ID: 24740456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YAP1 suppression inhibits autophagy and improves the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma.
    Gao Y; Peng Q; Li S; Zheng K; Gong Y; Xue Y; Liu Y; Lu J; Zhang Y; Shi X
    Exp Cell Res; 2023 Mar; 424(1):113486. PubMed ID: 36693491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
    Xia L; Huang W; Tian D; Zhang L; Qi X; Chen Z; Shang X; Nie Y; Wu K
    Hepatology; 2014 Mar; 59(3):958-73. PubMed ID: 24005989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma.
    Zhang F; Liu W; Meng F; Jiang Q; Tang W; Liu Z; Lin X; Xue R; Zhang S; Dong L
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
    Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
    Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
    Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.